Loading...
Sustained remissions beyond 4 years with epcoritamab monotherapy: long term follow-up results from the pivotal EPCORE NHL-1 trial in patients with relapsed or refractory large B-cell lymphoma
Karimi, Y. Cheah, C. Vose, J. Clausen, M. R. Cunningham, D. Farooq, U. Feldman, T. Ghesquieres, H. Jurczak, W. Linton, K.
Karimi, Y.
Cheah, C.
Vose, J.
Clausen, M. R.
Cunningham, D.
Farooq, U.
Feldman, T.
Ghesquieres, H.
Jurczak, W.
Linton, K.
Abstract
Description
Date
2025
Publisher
Collections
Files
Loading...
Found from Unpaywall
Adobe PDF, 179.73 KB
Keywords
Type
Article
Citation
Karimi Y, Cheah C, Vose J, Clausen MR, Cunningham D, Farooq U, et al. Sustained remissions beyond 4 years with epcoritamab monotherapy: long term follow-up results from the pivotal EPCORE NHL-1 trial in patients with relapsed or refractory large B-cell lymphoma. Blood. 2025 NOV 3;146.